326 related articles for article (PubMed ID: 21726264)
1. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
Fung RK; Kerridge IH
Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
[TBL] [Abstract][Full Text] [Related]
2. [A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease].
Morizane A; Takahashi J
Brain Nerve; 2012 Jan; 64(1):29-37. PubMed ID: 22223499
[TBL] [Abstract][Full Text] [Related]
3. Ethics and stem cell therapeutics for cardiovascular disease.
Sugarman J
Prog Cardiovasc Dis; 2007; 50(1):1-6. PubMed ID: 17631433
[TBL] [Abstract][Full Text] [Related]
4. Translational prospects for human induced pluripotent stem cells.
Csete M
Regen Med; 2010 Jul; 5(4):509-19. PubMed ID: 20632855
[TBL] [Abstract][Full Text] [Related]
5. [Ethical reflections on cell reprogramming].
Aznar Lucea J; Martínez M
Cuad Bioet; 2012; 23(78):287-99. PubMed ID: 23130744
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
Song M; Paul S; Lim H; Dayem AA; Cho SG
Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
[TBL] [Abstract][Full Text] [Related]
7. A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.
Romano G; Morales F; Marino IR; Giordano A
J Cell Physiol; 2014 Feb; 229(2):148-52. PubMed ID: 23881704
[TBL] [Abstract][Full Text] [Related]
8. First-in-human cell transplant trials in Parkinson's disease: The need for an improved informed consent process.
de Melo-Martín I; Hellmers N; Henchcliffe C
Parkinsonism Relat Disord; 2015 Aug; 21(8):829-32. PubMed ID: 26004682
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells and promises of neuroregenerative medicine.
Verma A; Verma N
Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes.
Katsuda T; Sakai Y; Ochiya T
J Stem Cells; 2012; 7(1):1-17. PubMed ID: 23550341
[TBL] [Abstract][Full Text] [Related]
11. A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research.
Patel P
J Med Ethics; 2006 Apr; 32(4):235-9. PubMed ID: 16574879
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine first-in-human research: challenges for informed consent.
King NM
J Law Med Ethics; 2012; 40(4):823-30. PubMed ID: 23289684
[TBL] [Abstract][Full Text] [Related]
13. Modeling human neurological disorders with induced pluripotent stem cells.
Imaizumi Y; Okano H
J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
[TBL] [Abstract][Full Text] [Related]
14. Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.
Carpenter MK; Couture LA
Regen Med; 2010 Jul; 5(4):569-79. PubMed ID: 20632860
[TBL] [Abstract][Full Text] [Related]
15. From bench to bedside and to health policies: ethics in translational research.
Petrini C
Clin Ter; 2011; 162(1):51-9. PubMed ID: 21448547
[TBL] [Abstract][Full Text] [Related]
16. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
Kumar D; Anand T; Kues WA
Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
[TBL] [Abstract][Full Text] [Related]
17. Ethics, ambiguity aversion, and the review of complex translational clinical trials.
Kimmelman J
Bioethics; 2012 Jun; 26(5):242-50. PubMed ID: 21241343
[TBL] [Abstract][Full Text] [Related]
18. Overview of the Moral Status of iPS Cells.
Martinho AM
New Bioeth; 2016 Jul; 22(2):148-154. PubMed ID: 28219287
[TBL] [Abstract][Full Text] [Related]
19. An introduction to induced pluripotent stem cells.
Hanley J; Rastegarlari G; Nathwani AC
Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
[TBL] [Abstract][Full Text] [Related]
20. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
Heffernan C; Sumer H; Verma PJ
J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
